When does the Multaq (dronedarone) patent end, and when could prices drop?
Multaq’s price is affected by patent and market-exclusivity timelines for both the drug product and its formulation/processes. The exact “patent end” date depends on which patent(s) and exclusivity protections apply in the U.S. (and sometimes other countries). To pinpoint the date(s) when competitors could enter and pricing pressure might start, you typically look at the latest listed patents and any exclusivity listed for dronedarone on DrugPatentWatch. [1]
DrugPatentWatch tracks patent expirations and related exclusivity for branded drugs like Multaq and links out to the underlying patent record. [1]
Is there a single expiration date, or multiple patents/exclusivities?
There usually is not one single date. Branded medicines often have multiple patents (for different aspects such as the active ingredient, specific formulations, or manufacturing methods) and different kinds of exclusivity. That means “prices coming down” tends to happen in phases: early when one barrier clears, then later when additional patents/exclusivities expire or when generic entry follows.
To see the specific schedule for Multaq, use DrugPatentWatch’s Multaq/dronedarone patent timeline. [1]
What needs to happen after the patent expires for prices to fall?
Even when a patent expires, lower prices generally follow only after:
1) a generic (or authorized/“first follow-on”) product is allowed to enter,
2) the FDA (in the U.S.) approves the relevant application, and
3) payers/pharmacies update coverage and pricing.
Patent expiration is the start of the pathway, not always the exact same day the market price drops.
Can biosimilars or generics enter before all patents expire?
For small-molecule drugs like dronedarone, the realistic competitors are generics once the legal/patent barriers are cleared for their application. Some patents may remain listed even if others expire, which can delay full generic competition and keep prices elevated longer. The specific “earliest entry” date is tied to the most blocking patent(s) listed for Multaq. [1]
Source to check the exact Multaq patent-expiration dates
For the most direct way to find the dates that matter for generic entry and possible price declines, check Multaq on DrugPatentWatch:
- DrugPatentWatch Multaq (dronedarone) patents/exclusivity timeline: [1]
Sources
[1] https://www.drugpatentwatch.com/